Matt T. Rosenberg, MD

Matt T. Rosenberg, MD
Medical Director, Mid-Michigan Health Centers, Jackson, MI

Diane K. Newman, RNC, MSN, CRNP
Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Health System, Philadelphia, PA

Christopher T. Tallman, BS
Research Fellow, Mid-Michigan Health Centers, Jackson, MI

Shari A. Page, CFNP
Mid-Michigan Health Centers, Jackson, MI

Correspondence: Matt T. Rosenberg, MD, Mid-Michigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; [email protected]

Dr. Rosenberg reported that he has received consulting fees and honoraria from Indevus Pharmaceuticals/ESPRIT Pharma, Pfizer, and GlaxoSmithKline for consulting, teaching/speaking, and serving on advisory committees; honoraria and consulting fees from Verathon Medical for consulting and serving on advisory committees; honoraria from Eli Lilly and Auxilium Pharmaceuticals for teaching/speaking; a research grant from Sanofi-Aventis; and consulting fees and honoraria from Ortho-McNeil for consulting and teaching/speaking.

Ms. Newman reported that she has received honoraria from Watson Pharmaceuticals, Pfizer, Astellas Pharma, GlaxoSmithKline, Novartis, and SCA Personal Care for teaching/speaking, as well as for serving on an advisory committee (for Watson) and for consulting (for SCA Personal Care).

Mr. Tallman and Ms. Page reported that they have no financial relationships that pose a potential conflict of interest with this article.

Matt T. Rosenberg, MD
Medical Director, Mid-Michigan Health Centers, Jackson, MI

Diane K. Newman, RNC, MSN, CRNP
Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Health System, Philadelphia, PA

Christopher T. Tallman, BS
Research Fellow, Mid-Michigan Health Centers, Jackson, MI

Shari A. Page, CFNP
Mid-Michigan Health Centers, Jackson, MI

Correspondence: Matt T. Rosenberg, MD, Mid-Michigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; [email protected]

Dr. Rosenberg reported that he has received consulting fees and honoraria from Indevus Pharmaceuticals/ESPRIT Pharma, Pfizer, and GlaxoSmithKline for consulting, teaching/speaking, and serving on advisory committees; honoraria and consulting fees from Verathon Medical for consulting and serving on advisory committees; honoraria from Eli Lilly and Auxilium Pharmaceuticals for teaching/speaking; a research grant from Sanofi-Aventis; and consulting fees and honoraria from Ortho-McNeil for consulting and teaching/speaking.

Ms. Newman reported that she has received honoraria from Watson Pharmaceuticals, Pfizer, Astellas Pharma, GlaxoSmithKline, Novartis, and SCA Personal Care for teaching/speaking, as well as for serving on an advisory committee (for Watson) and for consulting (for SCA Personal Care).

Mr. Tallman and Ms. Page reported that they have no financial relationships that pose a potential conflict of interest with this article.

Matt T. Rosenberg, MD
Medical Director, Mid-Michigan Health Centers, Jackson, MI

Diane K. Newman, RNC, MSN, CRNP
Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Health System, Philadelphia, PA

Christopher T. Tallman, BS
Research Fellow, Mid-Michigan Health Centers, Jackson, MI

Shari A. Page, CFNP
Mid-Michigan Health Centers, Jackson, MI

Correspondence: Matt T. Rosenberg, MD, Mid-Michigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; [email protected]

Dr. Rosenberg reported that he has received consulting fees and honoraria from Indevus Pharmaceuticals/ESPRIT Pharma, Pfizer, and GlaxoSmithKline for consulting, teaching/speaking, and serving on advisory committees; honoraria and consulting fees from Verathon Medical for consulting and serving on advisory committees; honoraria from Eli Lilly and Auxilium Pharmaceuticals for teaching/speaking; a research grant from Sanofi-Aventis; and consulting fees and honoraria from Ortho-McNeil for consulting and teaching/speaking.

Ms. Newman reported that she has received honoraria from Watson Pharmaceuticals, Pfizer, Astellas Pharma, GlaxoSmithKline, Novartis, and SCA Personal Care for teaching/speaking, as well as for serving on an advisory committee (for Watson) and for consulting (for SCA Personal Care).

Mr. Tallman and Ms. Page reported that they have no financial relationships that pose a potential conflict of interest with this article.

Matt T. Rosenberg, MD
Medical Director, Mid-Michigan Health Centers, Jackson, MI

Diane K. Newman, RNC, MSN, CRNP
Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Health System, Philadelphia, PA

Shari A. Page, CFNP
Mid-Michigan Health Centers, Jackson, MI

Correspondence: Matt T. Rosenberg, MD, Mid-Michigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; [email protected]

Dr. Rosenberg reported that he has received consulting fees and honoraria from Indevus Pharmaceuticals/ESPRIT Pharma, Pfizer, and GlaxoSmithKline for consulting, teaching/speaking, and serving on advisory committees; honoraria and consulting fees from Verathon Medical for consulting and serving on advisory committees; honoraria from Eli Lilly and Auxilium Pharmaceuticals for teaching/speaking; a research grant from Sanofi-Aventis; and consulting fees and honoraria from Ortho-McNeil for consulting and teaching/speaking.

Ms. Newman reported that she has received honoraria from Watson Pharmaceuticals, Pfizer, Astellas Pharma, GlaxoSmithKline, Novartis, and SCA Personal Care for teaching/speaking, as well as for serving on an advisory committee (for Watson) and for consulting (for SCA Personal Care).

Ms. Page reported that she has no financial relationships that pose a potential conflict of interest with this article.

Matt T. Rosenberg, MD
Medical Director, Mid-Michigan Health Centers, Jackson, MI

Diane K. Newman, RNC, MSN, CRNP
Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Health System, Philadelphia, PA

Shari A. Page, CFNP
Mid-Michigan Health Centers, Jackson, MI

Correspondence: Matt T. Rosenberg, MD, Mid-Michigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; [email protected]

Dr. Rosenberg reported that he has received consulting fees and honoraria from Indevus Pharmaceuticals/ESPRIT Pharma, Pfizer, and GlaxoSmithKline for consulting, teaching/speaking, and serving on advisory committees; honoraria and consulting fees from Verathon Medical for consulting and serving on advisory committees; honoraria from Eli Lilly and Auxilium Pharmaceuticals for teaching/speaking; a research grant from Sanofi-Aventis; and consulting fees and honoraria from Ortho-McNeil for consulting and teaching/speaking.

Ms. Newman reported that she has received honoraria from Watson Pharmaceuticals, Pfizer, Astellas Pharma, GlaxoSmithKline, Novartis, and SCA Personal Care for teaching/speaking, as well as for serving on an advisory committee (for Watson) and for consulting (for SCA Personal Care).

Ms. Page reported that she has no financial relationships that pose a potential conflict of interest with this article.

Matt T. Rosenberg, MD
Medical Director, Mid-Michigan Health Centers, Jackson, MI

Diane K. Newman, RNC, MSN, CRNP
Penn Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Health System, Philadelphia, PA

Shari A. Page, CFNP
Mid-Michigan Health Centers, Jackson, MI

Correspondence: Matt T. Rosenberg, MD, Mid-Michigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; [email protected]

Dr. Rosenberg reported that he has received consulting fees and honoraria from Indevus Pharmaceuticals/ESPRIT Pharma, Pfizer, and GlaxoSmithKline for consulting, teaching/speaking, and serving on advisory committees; honoraria and consulting fees from Verathon Medical for consulting and serving on advisory committees; honoraria from Eli Lilly and Auxilium Pharmaceuticals for teaching/speaking; a research grant from Sanofi-Aventis; and consulting fees and honoraria from Ortho-McNeil for consulting and teaching/speaking.

Ms. Newman reported that she has received honoraria from Watson Pharmaceuticals, Pfizer, Astellas Pharma, GlaxoSmithKline, Novartis, and SCA Personal Care for teaching/speaking, as well as for serving on an advisory committee (for Watson) and for consulting (for SCA Personal Care).

Ms. Page reported that she has no financial relationships that pose a potential conflict of interest with this article.

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Address: Matt T. Rosenberg, MD, Director, MidMichigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; e-mail [email protected]

Dr. Rosenberg has indicated that he is on the speakers’ bureau of Watson, Pfizer, and Ortho-McNeil, is a consultant for Pfizer and Ortho-McNeil, and has received grant or research support from Ortho-McNeil.

Dr. Dmochowski has indicated that he is a consultant for Watson and Indevus.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Address: Matt T. Rosenberg, MD, Director, MidMichigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; e-mail [email protected]

Dr. Rosenberg has indicated that he is on the speakers’ bureau of Watson, Pfizer, and Ortho-McNeil, is a consultant for Pfizer and Ortho-McNeil, and has received grant or research support from Ortho-McNeil.

Dr. Dmochowski has indicated that he is a consultant for Watson and Indevus.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Address: Matt T. Rosenberg, MD, Director, MidMichigan Health Centers, 214 N. West Avenue, Jackson, MI 49201; e-mail [email protected]

Dr. Rosenberg has indicated that he is on the speakers’ bureau of Watson, Pfizer, and Ortho-McNeil, is a consultant for Pfizer and Ortho-McNeil, and has received grant or research support from Ortho-McNeil.

Dr. Dmochowski has indicated that he is a consultant for Watson and Indevus.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.